Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-06-09
2009-02-17
Tsang, Cecilia J (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S013800, C514S014800, C514S015800, C514S016700, C514S017400, C514S018700, C530S300000, C530S324000, C530S325000, C530S326000, C530S327000, C530S328000, C530S329000, C530S330000, C530S331000
Reexamination Certificate
active
07491699
ABSTRACT:
A tubular or spherical nanostructure composed of a plurality of peptides, wherein each of the plurality of peptides includes no more than 4 amino acids and whereas at least one of the 4 amino acids is an aromatic amino acid.
REFERENCES:
patent: 2920080 (1960-01-01), Bucourt et al.
patent: 3042685 (1962-03-01), Roussel
patent: 3625973 (1971-12-01), Julia
patent: 3790596 (1974-02-01), Shkilkova et al.
patent: 3853987 (1974-12-01), Dreyer
patent: 3867517 (1975-02-01), Ling
patent: 3935074 (1976-01-01), Rubenstein et al.
patent: 3976639 (1976-08-01), Batcho et al.
patent: 3984533 (1976-10-01), Uzgiris
patent: 4036945 (1977-07-01), Haber
patent: 4299917 (1981-11-01), Berger et al.
patent: 4331647 (1982-05-01), Goldenberg
patent: 4626540 (1986-12-01), Capps et al.
patent: 4925673 (1990-05-01), Steiner et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 4970233 (1990-11-01), McHugh
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5270163 (1993-12-01), Gold et al.
patent: 5304470 (1994-04-01), Fischer et al.
patent: 5332648 (1994-07-01), Kihara et al.
patent: 5475096 (1995-12-01), Gold et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5556744 (1996-09-01), Weiner et al.
patent: 5567588 (1996-10-01), Gold et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5595877 (1997-01-01), Gold et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5637459 (1997-06-01), Burke et al.
patent: 5643768 (1997-07-01), Kawasaki
patent: 5658754 (1997-08-01), Kawasaki
patent: 5659041 (1997-08-01), Pollak et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5683867 (1997-11-01), Biesecker et al.
patent: 5705337 (1998-01-01), Gold et al.
patent: 5916642 (1999-06-01), Chang
patent: 6162828 (2000-12-01), Fukuda et al.
patent: 6251625 (2001-06-01), Bommarius et al.
patent: 6255286 (2001-07-01), Yanai et al.
patent: 6261569 (2001-07-01), Comis et al.
patent: 6303567 (2001-10-01), Findeis et al.
patent: 6309669 (2001-10-01), Setterstrom et al.
patent: 6326174 (2001-12-01), Joyce et al.
patent: 6359112 (2002-03-01), Kapurniotu et al.
patent: 6361861 (2002-03-01), Gao et al.
patent: 6593339 (2003-07-01), Eek et al.
patent: 6610478 (2003-08-01), Takle et al.
patent: 6613875 (2003-09-01), Ghadiri
patent: 6617114 (2003-09-01), Fowlkes et al.
patent: 6677153 (2004-01-01), Iversen
patent: 6689753 (2004-02-01), Soto-Jara
patent: 6762331 (2004-07-01), Hong et al.
patent: 6858318 (2005-02-01), Kogiso et al.
patent: 6976639 (2005-12-01), Williams et al.
patent: 2001/0041732 (2001-11-01), Gurley et al.
patent: 2002/0006954 (2002-01-01), Hensley et al.
patent: 2002/0086067 (2002-07-01), Choi et al.
patent: 2002/0151506 (2002-10-01), Castillo et al.
patent: 2003/0130484 (2003-07-01), Gordon et al.
patent: 2003/0144185 (2003-07-01), McGimpsey
patent: 2003/0158237 (2003-08-01), Saragovi et al.
patent: 2003/0225155 (2003-12-01), Fernandez-Pol et al.
patent: 2004/0001893 (2004-01-01), Stupp et al.
patent: 2004/0029830 (2004-02-01), Herbert
patent: 2004/0152672 (2004-08-01), Carson et al.
patent: 2005/0069950 (2005-03-01), Haynie
patent: 2006/0234947 (2006-10-01), Gazit
patent: 2007/0021345 (2007-01-01), Gazit
patent: 2007/0135334 (2007-06-01), Gazit
patent: 2007/0298043 (2007-12-01), Gazit et al.
patent: 2008/0009434 (2008-01-01), Reches et al.
patent: 3412445 (1985-10-01), None
patent: 10043282 (2002-03-01), None
patent: 0081122 (1983-06-01), None
patent: 0421946 (1991-04-01), None
patent: 59-044313 (1984-03-01), None
patent: 60-040061 (1985-02-01), None
patent: 63-044895 (1988-02-01), None
patent: 10-245342 (1998-09-01), None
patent: 2000-193661 (2000-07-01), None
patent: 2001-504334 (2001-04-01), None
patent: WO 80/00789 (1980-01-01), None
patent: WO 92/19253 (1992-11-01), None
patent: WO 97/16191 (1997-09-01), None
patent: WO 98/20135 (1998-05-01), None
patent: WO 99/42102 (1999-08-01), None
patent: WO 99/58652 (1999-11-01), None
patent: WO 00/24390 (2000-04-01), None
patent: WO 01/05421 (2001-01-01), None
patent: WO 01/10457 (2001-02-01), None
patent: WO 01/45726 (2001-06-01), None
patent: WO 01/49307 (2001-07-01), None
patent: WO 01/93836 (2001-12-01), None
patent: WO 02/072086 (2002-09-01), None
patent: WO 02/094857 (2002-11-01), None
patent: WO 03/013442 (2003-02-01), None
patent: WO 03/024443 (2003-03-01), None
patent: WO 03/039540 (2003-05-01), None
patent: WO 03/063760 (2003-07-01), None
patent: WO 03/070269 (2003-08-01), None
patent: WO 03/077866 (2003-09-01), None
patent: WO 2004/052773 (2004-06-01), None
patent: WO 2004/060791 (2004-07-01), None
patent: WO 2005/016339 (2005-02-01), None
patent: WO 2005/020809 (2005-03-01), None
patent: WO 2005/027901 (2005-03-01), None
patent: WO 2005/031362 (2005-07-01), None
patent: WO 2006/006172 (2006-01-01), None
patent: WO 2006/018850 (2006-02-01), None
patent: WO 2006/027780 (2006-03-01), None
patent: WO 2006/013552 (2006-09-01), None
patent: WO 2007/029003 (2007-03-01), None
patent: WO 2007/043048 (2007-04-01), None
patent: WO 01/49281 (2007-07-01), None
Hartgerink et al. “Self-Assembling Peptide Nanotubes”, Journal of the American Chemical Society, 118: 43-50, 1996.
Ajayan et al. “Applications of Carbon Nanotubes”, Topics of Applied Physics, 80: 391-425, 2001.
Görbitz “Nanotube Formation by Hydrophobic Dipeptides”, Chemistry, 7(23): 5153-5159, 2001.
Reches et al. “Amyloid Fibril Formation by Pentapeptide and Tetrapeptide Fragments of Human Calcitonin”, Journal of Biological Chemistry, 277(38): 35475-35480, 2002.
Haldar et al. “First Crystallographic Signature of the Highly Ordered Supramolecular Helical Assemblage From A Tripeptide Containing A Non-Coded Amino Acid”, Tetrahedron Letters, 43(14): 2653-2656, 2002.
Maji et al. “Fibril-Forming Model Synthetic Peptides Containing 3-Aminophenylacetic Acid”, Tetrahedron, 58(43): 8695-8702, 2002.
Hartgerink et al. “Peptide Nanotubes and Beyond”, Chemistry, A European Journal, 4(8): 1367-1372, 1998.
Ghadiri et al. “Self-Assembling Organic Nanotubes Based on A Cyclic Peptide Architecture”, Nature, 366: 324-327, 1993.
Horne et al. “A Heterocyclic Peptide Nanotube”, Journal of the American Chemical Society, 125(31): 9372-9376, 2003.
Reches et al. “Casting Metal Nanowires Within Discrete Self-Assembled Peptide Nanotubes”, Science, 300(5619): 625-627, 2003.
Adekore et al. “Carbon Nanotubes”, p. 1-11, 2001.
Brauer “GB-245 Nanotubes: Directions and Techno”, BCC, p. 1-14, 2000.
Martin et al. “The Emerging Field of Nanotube Biotechnology”, Nature Reviews, 2: 29-37, 2003.
Zhang et al. “Design of Nanostructured Biological Materials Through Self-Assembly of Peptides and Proteins”, Current Opinion in Chemical Biology, 6: 865-871, 2002.
Daenen et al. “The Wondrous World of Carbon Nanotubes”, p. 1-8, 2003.
Grady et al. “Axe-Txe, A Broad-Spectrum Proteic Toxin-Antitoxin System Specified by a Multidrug-Resistant, Clinical Isolate ofEnterococcus faecium”, Molecular Biology, 47(5): 1419-1432, 2003. Abstract, p. 1424, col. 1-p. 1426, col. 2, Fig.5.
Cherny et al. “The YefM Antitoxin Defines A Family of Natively Unfolded Proteins”, The Journal of Biological Chemistry, 279(9): 8252-8261, 2004.
Engelberg-Kulka et al. “Bacterial Programmed Cell Death Systems as Targets for Antibiotics”, Trends in Microbiology, 12(2): 66-71, 2004.
Forloni et al. “Anti-Amyloidogenic Activity of Tetracyclines: Studies In Vitro”, FEBS Letters, 487(3): 404-407, 2001. Abstract, Results, Figs.1,3.
Lansbury Jr. “Following Nature's Anti-Amyloid Strategy”, Nature Biotechnology, 19(2): 112-113, 2001.
Grateau “Le Curli du Coli: Une Variété Physiologique d'Amylose”, Medecine Sciences, 18(6-7): 664, 2002.
Cherny et al. “The Formation ofEscherichia coliCurli Amyloid Fibrils Is Mediated by Prion-Like Peptide Repeats”, Journal of Molecular Biology
Gazit Ehud
Reches Meital
Cordero Garcia Marcela M
Ramot At Tel Aviv University Ltd.
Tsang Cecilia J
LandOfFree
Peptide nanostructures and methods of generating and using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide nanostructures and methods of generating and using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide nanostructures and methods of generating and using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4079712